Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Targeted therapies in thyroid cancer Capdevila J; Perez-Garcia J; Obiols G; Tabernero JTarget Oncol 2009[Dec]; 4 (4): 275-85Differentiated thyroid carcinoma is the most frequent neoplasm of the endocrine system. Although thyroid cancer usually has an excellent prognosis, no therapeutic options are available for patients that develop metastases and are or became resistant to radioiodine therapy. The deeper knowledge of molecular aberrations that characterize tumor growth has provided novel targets in cancer therapy. Several proteins have been implicated as having a crucial role in the carcinogenesis of differentiated thyroid cancer, such as those involved in RET/PTC-RAS-RAF-MAPK pathway. Moreover, vascular aberrations and angiogenesis equilibrium have also been related to tumor growth. The development of new, targeted therapies and their encouraging initial results have opened a hopeful opportunity of treatment for these orphan therapy tumor patients.|Animals[MESH]|Carcinoma, Papillary/drug therapy/*genetics[MESH]|Cell Line, Tumor[MESH]|Cell Transformation, Neoplastic[MESH]|Disease Models, Animal[MESH]|Drug Delivery Systems/*methods[MESH]|Drug Design[MESH]|Genes, ras/genetics/physiology[MESH]|Humans[MESH]|Mice[MESH]|Mice, Nude[MESH]|Neoplasm Recurrence, Local[MESH]|Neoplasm Transplantation[MESH]|Protein Kinase Inhibitors/administration & dosage[MESH]|Proto-Oncogene Proteins c-ret/*genetics/metabolism[MESH]|Rats[MESH]|Thyroid Neoplasms/*genetics/therapy[MESH]|Xenograft Model Antitumor Assays[MESH] |
